CD47 and hepatocellular carcinoma: It has been reported that cell migration ability was significantly inhibited following the treatment of HCC cells with a Let-7i-5p antisense inhibitor and recombinant TSP1, whereas combined treatment with 3F352 rescued these responses, suggesting the existence of an autocrine/paracrine TSP1-CD47 mechanism in HCC cells (20).